Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vaginal Lubricants’ Ability To Kill HIV Merits Human Study – Researchers

This article was originally published in The Tan Sheet

Executive Summary

Clinical trials testing the protective effect of three FDA-approved vaginal lubricants and preparations against HIV should be conducted in populations at high-risk for contracting the virus, University of Texas Medical Branch at Galveston researchers state
Advertisement

Related Content

Nonoxynol-9 Microbicidal Ineffectiveness Cited In JAMA Study, Editorial
Nonoxynol-9 Microbicidal Ineffectiveness Cited In JAMA Study, Editorial
Nonoxynol-9 Microbicidal Ineffectiveness Cited In JAMA Study, Editorial
Nonoxynol-9 Spermicides May Need Review After Clinical Trial Results
Nonoxynol-9 Spermicides May Need Review After Clinical Trial Results
Reprotect Buffergel Phase II Data May Serve As Basis For NDA

Topics

Advertisement
UsernamePublicRestriction

Register

PS093533

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel